Reviscon Mono is a single-dose joint injection containing sterile sodium hyaluronate to replenish joint fluid and support cartilage protection. It is delivered to the joint in the form of a high concentration, high molecular weight hyaluronic acid gel to reduce friction and cushion shock.
A single injection of Reviscon Mono can provide lasting relief from joint pain and stiffness for up to several months. As only one treatment is required, it offers patients a convenient alternative to multiple injections. It improves joint mobility and quality of life in osteoarthritis (joint wear). Its high purity and viscosity formulation allows it to act quickly, with improvements in the joint being felt within days. Treatment is carried out by an orthopaedic specialist, ensuring accurate delivery to the problem joint and minimising discomfort.